0001209191-23-012356.txt : 20230223 0001209191-23-012356.hdr.sgml : 20230223 20230223184303 ACCESSION NUMBER: 0001209191-23-012356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230221 FILED AS OF DATE: 20230223 DATE AS OF CHANGE: 20230223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jiang Wenbin CENTRAL INDEX KEY: 0001872873 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40632 FILM NUMBER: 23661642 MAIL ADDRESS: STREET 1: C/O CYTEK BIOSCIENCES, INC. STREET 2: 46107 LANDING PARKWAY CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cytek Biosciences, Inc. CENTRAL INDEX KEY: 0001831915 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 472547526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 47215 LAKEVIEW BOULEVARD CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: (877) 922-9835 MAIL ADDRESS: STREET 1: 47215 LAKEVIEW BOULEVARD CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: Cytek BioSciences, Inc. DATE OF NAME CHANGE: 20201110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-21 0 0001831915 Cytek Biosciences, Inc. CTKB 0001872873 Jiang Wenbin C/O CYTEK BIOSCIENCES, INC. 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 1 1 0 0 President and CEO Common Stock 2023-02-21 4 M 0 6758 A 7727072 D Common Stock 2023-02-21 4 F 0 2633 10.97 D 7724439 D Restricted Stock Units 2023-02-21 4 M 0 6758 0.00 D Common Stock 6758 78852 D Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. Represents the number of shares withheld by and surrendered to the Issuer on February 21, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award. The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18. /s/ Valerie Barnett, Attorney-in-Fact for Wenbin Jiang 2023-02-23